Eric Przybyszewski

7PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Gastroenterology and hepatology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 12, 2026
Glucagon-Like Peptide-1 Receptor Agonist Use and Liver-Related Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes in the All of Us Research Program.

|Dec 16, 2025
Association of Sodium-Glucose Cotransporter-2 Inhibitors With Reduced Hepatocellular Carcinoma Risk in Patients With Type 2 Diabetes.

Jonggi Choi, Vy H Nguyen, Eric Przybyszewski

|Mar 29, 2024
A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis.

Marc S Sherman, Prasanna K Challa, Eric M Przybyszewski

|Sep 13, 2023
Unmet Needs in the Post-Direct-Acting Antiviral Era: Hepatocarcinogenesis After Hepatitis C Virus Eradication.

Eric M Przybyszewski, Raymond T Chung

|May 23, 2023
The incidence and natural history of ascites after liver transplantation.

Patricia P Bloom, Timothy Gilbert, Keli Santos-Parker

Pageof 2

Frequent Collaborators

2 joint publications

Erik Almazan

2 joint publications

Tracey G Simon

2 joint publications

Jiunn Song

2 joint publications

Vy H Nguyen